Last updated on November 2017

Triple IN Study (Inhibition of Incisional Infections): Phase 3 Study of Efficacy and Safety of Topical E-101 Solution to Prevent Incisional Infections among Colorectal Surgery Patients


Brief description of study

Triple IN Study (Inhibition of Incisional Infections): Phase 3 Study of Efficacy and Safety of Topical E-101 Solution to Prevent Incisional Infections among Colorectal Surgery Patients

Detailed Study Description

Wound infections can occur in about 12-25% of patients undergoing colorectal surgery despite routine efforts to prevent them. This study is being done to assess the safety and ability of an experimental drug called E-101 Solution (study drug), in addition to routine efforts, to prevent incisional wound infection for 30 days after colorectal surgery.

Clinical Study Identifier: TX81341

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Tammy Fisher, RN

Baylor Scott & White Research Institute
Dallas, TX USA
  Connect »